Geriatric Oncology News

Although most cancer centers may not screen every patient at every visit, I believe in it whole-heartedly, and this is what we do at Rush University. If we believe in the value of asking patients how they are doing, it’s hard to justify excluding certain visits from this practice, particularly considering we aren’t very good about predicting when any individual patient might be struggling.

Studies consistently have shown patients with cancer have a higher risk for suicide than the general public.

THOROFARE, NJ — Healio is set to host the inaugural hematology/oncology Disruptive Innovators Award Reception during the American Society of Clinical Oncology Annual Meeting. The event will take place on June 4, 2022, at the Hyatt Regency McCormick Place in Chicago, Illinois.

Andrew Chapman, DO, FACP, has been named director of Sidney Kimmel Cancer Center — Jefferson Health.

Older Black adults with newly diagnosed gastrointestinal malignancies appeared more likely to be frail and report functional impairments than their white counterparts, according to study results published in Cancer.

Machine learning gives us a somewhat different lens for understanding data. It should not be an exclusive approach, but it could augment our understanding of this population of patients.

Addressing inequities in health care has become a priority across all branches of medicine, including oncology.

Similar proportions of older women with node-negative and node-positive early breast cancer had Oncotype Dx breast recurrence scores that would qualify them for adjuvant chemotherapy, according to study results.

Second-line therapy with axicabtagene ciloleucel conferred a greater than eightfold increase in median EFS compared with standard-of-care treatment for older patients with diffuse large B-cell lymphoma, according to phase 3 study results.

Older patients with cancer benefited from single-agent immune checkpoint inhibitors but had higher rates of adverse events and therapy discontinuation with increasing age, according to results of a retrospective study in JAMA Oncology.